Pemetrexed Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/4 mL vial, 500 mg/20 mL vial

Reference Brands: Alimta(EU & US)

Category: Oncology Cancer Care

Pemetrexed Injection 100 mg/4 mL and 500 mg/20 mL is used to treat non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. Approved in the U.S. and EU under the brand name Alimta, it is a key chemotherapy drug for oncology treatments. Available for IV infusion, it helps slow tumor growth by inhibiting DNA and RNA synthesis. Pemetrexed Injection is available in Injection and strengths such as 100 mg/4 mL vial, 500 mg/20 mL vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Pemetrexed Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Pemetrexed Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Pemetrexed Injection 100 mg/4 mL and 500 mg/20 mL is a vital chemotherapy drug used to treat non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. As an IV infusion, Pemetrexed works by inhibiting enzymes crucial for DNA and RNA synthesis, slowing tumor growth. Approved in the U.S. and EU under the brand name Alimta, it is a cornerstone in the treatment of these challenging cancers. With both 100 mg and 500 mg vial strengths, Pemetrexed is crucial for oncology B2B distribution, supporting hospitals and oncology centers in treating advanced lung and mesothelioma cancers.